✦ LIBER ✦

Successful treatment of recurrent thrombotic thrombocytopenic purpura with plasmapheresis and vincristine

✍ Scribed by S. Van Gool; P. Brock; P. Van Laer; R. Van Damme-lombaerts; W. Proesmans; M. Casteels-Van Daele

Publisher: Springer
Year: 1994
Tongue: English
Weight: 292 KB
Volume: 153
Category: Article
ISSN: 0340-6997
DOI: 10.1007/bf01957008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thrombotic thrombocytopenic purpura: Tre

Thrombotic thrombocytopenic purpura: Treatment with plasmapheresis

✍ Jonathan B. Blitzer; James M. Granfortuna; Dr. Arlan J. Gottlieb; J. Robert Smit 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 738 KB

Rapid improvement of thrombotic thromboc

Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis

✍ Jeanna L. Welborn; Pam Emrick; Maxine Acevedo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 386 KB 👁 1 views

Vincristine as treatment for recurrent e

Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura

✍ F. Ferrara; M. Annunziata; F. Pollio; S. Palmieri; C. Copia; G. Mele; B. Pocali; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 40 KB

Successful treatment of thrombotic throm

Successful treatment of thrombotic thrombocytopenia purpura by vincristine

✍ Marshall T. Schreeder; Josef T. Prchal 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 267 KB

Successful treatment of thrombotic throm

Successful treatment of thrombotic thrombocytopenic purpura with high-dose corticosteroid

✍ Michihiro Toyoshige; Yuzuru Zaitsu; Koichiro Okafuji; Yasushi Inoue; Yukio Hiros 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

Treatment of thrombotic thrombocytopenic

Treatment of thrombotic thrombocytopenic purpura: A role for early vincristine administration

✍ Catherine Mazzei; Samuel Pepkowitz; Ellen Klapper; Dennis Goldfinger 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 23 KB 👁 2 views

Plasma exchange (PE) is considered first-line treatment for thrombotic thrombocytopenic purpura (TTP) to the point that many clinicians regard it as definitive therapy. Studies have reported response rates to PE ranging from 39% to 78%. In our experience, a minority of patients have been cured solel